Quaker Chemical Corporation (NYSE:KWR) stock has reached a 52-week low, trading at $136.75. This price level reflects a significant downturn for the company, which has seen a -31.43% change over the past year. According to InvestingPro analysis, the stock appears undervalued at current levels, with technical indicators suggesting oversold conditions. The specialty chemical company, known for its process fluids and coatings for metal and manufacturing industries, has faced market challenges that have impacted its stock performance. Despite these challenges, the company maintains strong fundamentals with a healthy current ratio of 2.54 and has maintained dividend payments for 53 consecutive years. Investors are closely monitoring Quaker Chemical’s strategies for recovery and future growth as the company navigates through the current economic landscape. InvestingPro subscribers can access detailed analysis and 8 additional key insights about KWR’s financial health and growth prospects.
In other recent news, Quaker Chemical Corporation reported a 6% decrease in net sales year-over-year, totaling $462 million. Despite this, the company maintained stable gross margins and reported an adjusted EBITDA of $79 million. Quaker Chemical also achieved over $20 million in annual cost savings from its Cost and Optimization Program, maintaining a strong cash position with over $200 million in cash.
The company announced leadership changes, with Joseph Berquist appointed as the new Chief Executive Officer and President. Additionally, Melissa Leneis, Senior Vice President and Chief Human Resources Officer, has left the company, and Andrew E. Tometich, former CEO, has finalized a separation agreement with the company.
Quaker Chemical’s Board of Directors approved long-term incentive equity compensation awards to Tom Coler, Executive Vice President and Chief Financial Officer, and Jeewat Bijlani, Executive Vice President and Chief Strategy Officer. The awards are linked to the company’s Total (EPA:TTEF) Shareholder Return relative to the S&P 1500 Chemicals Index.
Piper Sandler, an analyst firm, adjusted its price target for Quaker Chemical, raising it to $200 from the previous $190, while keeping an Overweight rating on the stock. This adjustment was attributed to expected seasonal trends and a more gradual economic recovery in Asia and the European Union. These are recent developments in Quaker Chemical’s business operations and financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.